NENCI, Giuseppe Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 2.327
AS - Asia 1.954
EU - Europa 1.793
SA - Sud America 196
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.298
Nazione #
US - Stati Uniti d'America 2.270
HK - Hong Kong 741
SG - Singapore 656
UA - Ucraina 483
IE - Irlanda 328
RU - Federazione Russa 219
CN - Cina 182
BR - Brasile 173
SE - Svezia 160
VN - Vietnam 150
DE - Germania 134
FI - Finlandia 130
IT - Italia 127
GB - Regno Unito 74
TR - Turchia 74
KR - Corea 64
FR - Francia 45
CA - Canada 35
IN - India 19
NL - Olanda 16
PL - Polonia 15
BE - Belgio 14
BD - Bangladesh 13
CH - Svizzera 13
MX - Messico 11
ZA - Sudafrica 11
AR - Argentina 10
JP - Giappone 10
PK - Pakistan 9
UZ - Uzbekistan 9
AT - Austria 5
CZ - Repubblica Ceca 5
EG - Egitto 5
GR - Grecia 5
IQ - Iraq 5
PY - Paraguay 5
ES - Italia 4
LB - Libano 4
LT - Lituania 4
BG - Bulgaria 3
ID - Indonesia 3
MY - Malesia 3
SA - Arabia Saudita 3
AM - Armenia 2
AO - Angola 2
EC - Ecuador 2
EU - Europa 2
JO - Giordania 2
MA - Marocco 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
CU - Cuba 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
ME - Montenegro 1
MU - Mauritius 1
MZ - Mozambico 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
VE - Venezuela 1
Totale 6.298
Città #
Hong Kong 741
Singapore 423
Chandler 342
Dublin 328
Jacksonville 270
San Mateo 201
Ashburn 115
Boardman 113
Santa Clara 96
Dong Ket 88
Medford 84
Princeton 84
Ann Arbor 79
Altamura 72
Moscow 70
Izmir 68
Seoul 64
Wilmington 64
Andover 48
Beijing 48
Des Moines 48
Lawrence 43
Helsinki 34
Munich 33
Los Angeles 27
Piscataway 26
New York 25
Saint Petersburg 23
Ho Chi Minh City 22
Shanghai 21
The Dalles 16
Brussels 14
Ottawa 14
Norwalk 13
Perugia 13
Denver 12
Woodbridge 12
Montreal 11
Turku 11
Dallas 10
Hanoi 10
São Paulo 10
Houston 9
London 9
Tokyo 9
Macerata 8
Stockholm 8
Brooklyn 7
Council Bluffs 7
Den Haag 7
Frankfurt am Main 7
San Francisco 7
Toronto 7
Auburn Hills 6
Chennai 6
Da Nang 6
Johannesburg 6
Phoenix 6
San Paolo di Civitate 6
Amsterdam 5
Belo Horizonte 5
Cairo 5
Hải Dương 5
Poplar 5
Atlanta 4
Charlotte 4
Chicago 4
Dearborn 4
Guangzhou 4
Kraków 4
Manchester 4
Mexico City 4
Mumbai 4
Orem 4
Rio de Janeiro 4
Warsaw 4
Ankara 3
Boston 3
Brasília 3
Catanduva 3
Concord 3
Curitiba 3
Dhaka 3
Ninh Bình 3
Philadelphia 3
Porto Alegre 3
Sofia 3
Viçosa 3
Amman 2
Annapolis 2
Aracaju 2
Asunción 2
Baghdad 2
Betim 2
Blumenau 2
Bắc Ninh 2
Cape Town 2
Capua 2
Casablanca 2
Casalbordino 2
Totale 4.100
Nome #
Fisiopatologia dell'emostasi 520
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 154
A case of Capnocytophaga canimorsus sepsis and suspected myocardial injury following a dog bite 147
Oral anticoagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS) 139
Absorption and antithrombotic activity of unfractioned heparin after intraduodenal administration in rats 109
Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma 107
Effect of cloricromene on intermittent claudication. A randomized double-blind, placebo controlled trial in patients treated with aspirin: effect on claudication distance and quality of life 99
Activation of phospholipase A2 and ß-thromboglobulin release in human platelets stimulated with thrombin and fluoro aluminate 99
OAT with POC devices and remote computer monitoring in the setting of the Italian NHS: a controlled clinical trial 98
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism 96
LMWH or Ximelagatran versus VKA in the prevention of VTE after major knee surgery: a meta-analysis of randomized controlled trials 95
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 94
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 94
Choline plasmalogen biosynthesis by transmethylation in human platelets 88
Assessment of occlusion of the vascular access in patients on chronic hemodialysis: comparison of physical examination with continuous-wave doppler ultrasound. 88
Peripheral arteriopathy: effects of cloricromene on claudication and quality of life, a randomized double blind,,placebo controlled trial in patients treated with aspirin 87
Effect of different plasma expanders on erythrocyte filterability 87
Risk factor for upper limb deep vein thrombosis 86
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 84
Terapia anticoagulante orale con l’impiego di tecnologia POC e monitoraggio via web nell’ambito del Sistema Sanitario Nazionale Italiano 83
Differences between human platelets erythrocyte membranes.A spectroscopic study with particular refernce to IR and Laser Raman spectroscopy. 83
Profilassi della trombosi venosa profonda in neurochirurgia 80
Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. 80
Effect of pentoxifylline on platelet aggregation 80
Effect of glyceryl trinitrate on distensibility of peripheral muscular arteries in humans is not mediated by prostaglandins 80
Diagnostica generale delle malattie emorragiche. 79
A randomized study on eversion versus standard carotid endarterectomy: Study design and preliminary results: The EVEREST Trial 79
Erythocyte deformability changes in normal pregnancy and preeclampsia 78
Cholinephosphotransferase activity in human platelet 78
Kidney failure and endothelial disfunction: effects of haemodialysis 77
Characterization of N, N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets. 77
Intracellular signal transduction mechanisms regulating the release of lysosomes by activated human platelets 77
Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial 75
Clotting activation after blood transfusion in patients receiving 5-fluorouracil and mitomycin -C treatment 72
Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression 71
Eversion versus conventional carotid endarterectomy: late results of a prospective multicenter randomized trial 71
Evaluation of the antithrombotic activity of unfractioned heparin or nadroparine after oral administration in man 70
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 69
Platelets release their lysosomal content in vivo in humans upon activation 68
Pharmacoeconomic evaluation of the management of oral anticoagulant treatment with point-of-care devices in the Italian national health care system 67
Platelet activation and allergic asthma. 67
Evidence that cytosolic phospholipase A2 is down-regulated by protein kinase C in intact human platelets stimulated with fluoroaluminate. 67
Treatment of intermittent claudication with mesoglycan - a placebo-controlled, double - blind study. 66
Risk factor for upper extremity deep vein thrombosis 65
Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition. 65
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation 65
Erythrocyte deformability in pre-eclamptic women and their newborn in the evaluation of microcirculatory impairment. 64
Interaction beteween thrombophilic genetic mutations and clinical bleeding in patients undergoing chronic oral anticoagulant treatment 63
High shear stress induces nitric oxide synthesis in human platelets - 63
Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement 63
Safety and efficacy of ximelagatran: meta-analysis of the controlled randomized trials for the prophylaxis or treatment of venous thromboembolism 63
Human blood platelets release their lysosomal content ''in vivo'' at a localized site of platelet activation 62
Generation of arachidonic acid metabolites from stimulated whole blood in patients with chronic myeloproliferative disorders 62
Inhibition of fluid phase and fibrin bound thrombin: effect of heparin, r-hirudin, PEG-rm-hirudin and a thrombin exosite inhibitor 61
Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report 61
Ultraviolet spectra of membrane-rich human platelet particulates. Normal data and specular abnormalities in hypo- and hyper-betalipoproteinemia 61
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. 60
Evidence for platelet activation in allergic asthma. 59
Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C. 58
Infusion of vincristine-loaded platelets in acute ITP refractory to steroids: an alternative to splenectomy 58
Vincristine-loaded platelets for autoimmune thrombocytopenic purpura 57
Red cell deformability alterations in normal late pregnancy: possible role of plasma components 57
Intrinsically defective or exhausted platelets in hairy cell leukemia? 55
Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic diseases. 54
Thrombolytic therapy for thromboembolism of the vertebrobasilar artery. 54
Thrombolytic therapy for thromboembolism of vertebrobasilar artery. 53
Platelet glycohydrolase activities: characterization and release 52
Liquid Nitrogen Snap Frozen Saphenous Vein for Vascular Access in Dialysis 52
Intraoperative assessment of technical perfection in carotid endarterectomy: a prospective analysis of 1305 completion procedures 52
Platelets release lambda-granules (lysosomes) “in vivo” in humans upon activation 52
Heparin and local haemostasis 51
Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets. Role of adenylylcyclase up-regulation 50
Platelets release lambda-granules (lysosomes) in vivo in humans upon activation 50
La safena omologa crioconservata come accesso dialitico: valutazione biologica e clinica 50
Vinca-loaded platelets 49
The reduced erythrocyte deformability in pre-eclampsia is due to altered plasma to red blood cell interactions 49
Interactions between platelets, other cells and eicosanoids in hypertension. 47
Platelets and asthma 46
In vitro and ex vivo effect of indobufen on red blood cell deformability. 45
New pyridazinone derivatives as inhibitors of platelet aggregation. 44
Thromboxane does not play a significant role in acute, cold induced vasoconstriction in raynaud’s phenomenon 44
Ruolo del sistema emostatico nella patologia cardiovascolare. Generalità. 44
Treatment of intermittent claudication with medoglycan- a placebo-controlled, double-blind study 44
Human blood platelets release their lysosomal content “in vivo” at a localised site of platelet activation 35
Platelet glycohydrolase activities: Characterization and release 27
Totale 6.431
Categoria #
all - tutte 28.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021386 0 0 0 0 0 26 76 1 90 16 80 97
2021/2022641 9 117 18 27 20 2 6 234 5 16 71 116
2022/20231.149 96 195 26 84 83 140 0 51 417 1 34 22
2023/2024931 30 43 22 4 6 2 645 12 33 17 71 46
2024/20251.054 9 150 24 26 210 30 22 63 222 65 158 75
2025/20261.040 166 100 91 268 279 136 0 0 0 0 0 0
Totale 6.431